EP0111209A2 - Sorbit, process for its preparation and its use - Google Patents
Sorbit, process for its preparation and its use Download PDFInfo
- Publication number
- EP0111209A2 EP0111209A2 EP83111682A EP83111682A EP0111209A2 EP 0111209 A2 EP0111209 A2 EP 0111209A2 EP 83111682 A EP83111682 A EP 83111682A EP 83111682 A EP83111682 A EP 83111682A EP 0111209 A2 EP0111209 A2 EP 0111209A2
- Authority
- EP
- European Patent Office
- Prior art keywords
- sorbitol
- tablets
- pressing force
- solution
- pressed
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 7
- 238000000034 method Methods 0.000 title claims description 11
- 239000000600 sorbitol Substances 0.000 claims abstract description 79
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 claims abstract description 76
- 238000003825 pressing Methods 0.000 claims abstract description 22
- 238000004519 manufacturing process Methods 0.000 claims abstract description 13
- 238000005984 hydrogenation reaction Methods 0.000 claims abstract description 11
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 10
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims abstract description 9
- 238000005452 bending Methods 0.000 claims abstract description 7
- 239000008103 glucose Substances 0.000 claims abstract description 7
- 238000002844 melting Methods 0.000 claims abstract description 5
- 230000008018 melting Effects 0.000 claims abstract description 5
- HIMQVZDNGULBFJ-HUNMEVQMSA-N (2R,3R,4R,5S)-hexane-1,2,3,4,5,6-hexol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO HIMQVZDNGULBFJ-HUNMEVQMSA-N 0.000 claims abstract 2
- 239000007921 spray Substances 0.000 claims abstract 2
- 238000001694 spray drying Methods 0.000 claims description 13
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical class OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 71
- 239000003826 tablet Substances 0.000 description 33
- 239000000243 solution Substances 0.000 description 17
- 239000000047 product Substances 0.000 description 12
- 239000006227 byproduct Substances 0.000 description 9
- 239000000654 additive Substances 0.000 description 8
- 239000007787 solid Substances 0.000 description 7
- 238000002425 crystallisation Methods 0.000 description 6
- 230000008025 crystallization Effects 0.000 description 6
- 239000004615 ingredient Substances 0.000 description 6
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 6
- 238000005299 abrasion Methods 0.000 description 5
- 239000003054 catalyst Substances 0.000 description 5
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 4
- 239000007937 lozenge Substances 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 3
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 3
- 229930195725 Mannitol Natural products 0.000 description 3
- 239000007868 Raney catalyst Substances 0.000 description 3
- 229910000564 Raney nickel Inorganic materials 0.000 description 3
- 238000007906 compression Methods 0.000 description 3
- 230000006835 compression Effects 0.000 description 3
- 239000000975 dye Substances 0.000 description 3
- 239000001257 hydrogen Substances 0.000 description 3
- 229910052739 hydrogen Inorganic materials 0.000 description 3
- 230000001788 irregular Effects 0.000 description 3
- 235000019359 magnesium stearate Nutrition 0.000 description 3
- 239000000594 mannitol Substances 0.000 description 3
- 235000010355 mannitol Nutrition 0.000 description 3
- 235000021092 sugar substitutes Nutrition 0.000 description 3
- 239000003765 sweetening agent Substances 0.000 description 3
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 244000299461 Theobroma cacao Species 0.000 description 2
- 235000009470 Theobroma cacao Nutrition 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 239000008121 dextrose Substances 0.000 description 2
- 239000000314 lubricant Substances 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 238000005507 spraying Methods 0.000 description 2
- 239000007858 starting material Substances 0.000 description 2
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 description 1
- 108010011485 Aspartame Proteins 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 1
- 238000005169 Debye-Scherrer Methods 0.000 description 1
- 241000132519 Galactites Species 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 239000000605 aspartame Substances 0.000 description 1
- 235000010357 aspartame Nutrition 0.000 description 1
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 description 1
- 229960003438 aspartame Drugs 0.000 description 1
- 238000000889 atomisation Methods 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 230000018044 dehydration Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- 239000008367 deionised water Substances 0.000 description 1
- 229910021641 deionized water Inorganic materials 0.000 description 1
- 208000002925 dental caries Diseases 0.000 description 1
- 238000011033 desalting Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 238000000113 differential scanning calorimetry Methods 0.000 description 1
- 238000007907 direct compression Methods 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 239000008240 homogeneous mixture Substances 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 229960004903 invert sugar Drugs 0.000 description 1
- 229940041616 menthol Drugs 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000011321 prophylaxis Methods 0.000 description 1
- 235000019204 saccharin Nutrition 0.000 description 1
- CVHZOJJKTDOEJC-UHFFFAOYSA-N saccharin Chemical compound C1=CC=C2C(=O)NS(=O)(=O)C2=C1 CVHZOJJKTDOEJC-UHFFFAOYSA-N 0.000 description 1
- 229940081974 saccharin Drugs 0.000 description 1
- 239000000901 saccharin and its Na,K and Ca salt Substances 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 150000005846 sugar alcohols Chemical class 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C31/00—Saturated compounds having hydroxy or O-metal groups bound to acyclic carbon atoms
- C07C31/18—Polyhydroxylic acyclic alcohols
- C07C31/26—Hexahydroxylic alcohols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C29/00—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring
- C07C29/74—Separation; Purification; Use of additives, e.g. for stabilisation
- C07C29/76—Separation; Purification; Use of additives, e.g. for stabilisation by physical treatment
- C07C29/78—Separation; Purification; Use of additives, e.g. for stabilisation by physical treatment by condensation or crystallisation
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C31/00—Saturated compounds having hydroxy or O-metal groups bound to acyclic carbon atoms
- C07C31/18—Polyhydroxylic acyclic alcohols
- C07C31/24—Tetrahydroxylic alcohols, e.g. pentaerythritol
Definitions
- the invention relates to a modified sorbitol with improved tabletting properties.
- Sorbitol is a widely used tablet base that is used, among other things, for chewable and lozenges.
- the particular advantage of sorbitol lies in the fact that it is in principle also suitable for direct pressing without any additional auxiliaries and additives.
- Sorbitol is generally obtained by hydrogenating starch hydrolyzates or by hydrogenating invert sugar with subsequent separation of mannitol. In solid form, it can be obtained both by crystallization and by spray drying.
- Such sorbitol is generally not very suitable for producing satisfactory compressed products.
- Special processes have therefore been developed to produce a sorbitol suitable for better compression.
- DE-A1 3009 875 describes a very special, complicated crystallization process by which a sorbitol suitable for pressing can be produced.
- Another special crystallization process is described in EP-Al 32288.
- the invention also relates to a process for the production of sorbitol with improved tabletting properties, a sorbitol solution being obtained by hydrogenation of glucose-containing solutions and being obtained therefrom by spray drying, which is characterized in that a solution of crystallized glucose at a temperature below 170.degree is hydrogenated and the sorbitol solution thus obtained is spray-dried at a temperature of 140 to 170 ° C so that the product obtained has a water content of less than 1%.
- the invention also relates to the use of sorbitol for the production of pressed preparations.
- sorbitol An essential prerequisite for the production of the sorbitol according to the invention is the use of crystallized glucose as the starting material for the hydrogenation. It is equally important that the hydrogenation takes place under gentle conditions, i. H. at temperatures which are below approximately 170 ° C., preferably below approximately 160 ° C.
- the hydrogenation can otherwise be carried out under the usual conditions.
- a hydrogenation catalyst such as. B. a supported nickel catalyst, especially Raney nickel, hydrogenated at hydrogen pressures of about 150 to about 200 bar, especially about 150 to about 180 bar.
- the solution is then cooled and separated from the catalyst. If necessary, the catalyst can be reused after working up.
- the analysis of the solutions shows that considerable amounts of by-products are formed even at temperatures of 170 ° C. Although these by-products do not interfere with the usability of the sorbitol as a sugar substitute, it has surprisingly been found that these by-products greatly impair the compressibility of the sorbitol.
- the sorbitol solution obtained from the hydrogenation solution after separating the catalyst and desalting can be used directly for spray drying.
- the solids content is previously adjusted to about 65 to about 75% by weight.
- the spraying is carried out by atomization using a centrifugal atomizer in a dry, centrifugally blown air stream heated to a temperature of 140-170 ° C.
- the amount of the sorbitol solution supplied and the hot air blown in are adjusted so that the sorbitol is dried to a water content of about 0.3 to about 1% by weight. In any case, the water content should be below 1% by weight.
- the Sorbitteilchen which are thereby obtained by dehydration of the Sorbitanströpfchen are heated during the spray drying to a temperature of about 50 to about 70 0 C, while the blown-in air is cooled to about the same temperature.
- the sorbitol is collected in containers and, after cooling, is suitable for the production of compressed products.
- the material obtained by the process according to the invention can surprisingly be pressed with the addition of small amounts of a conventional lubricant, such as magnesium stearate, without sticking to the tabletting dies.
- the sorbitol according to the invention is a sorbitol which, according to the Debye-Scherrer diagram, essentially consists of y-sorbitol.
- the sorbitol according to the invention has an irregular surface.
- the melting behavior differential scanning calorimetry
- the sorbitol according to the invention shows a sharp peak at approximately 96 ° C.
- the bulk density (according to DIN 53 912) is about 0.3 to 0.6 g / ml
- the tamped density accordinging to DIN 53 194) is about 0.4 to 0.7 g / ml.
- the sorbitol according to the invention has a relatively high specific surface area of approximately 0.7 to approximately 1.5 m 2 / g.
- the particle size can be controlled within wide limits by the spray drying process, but is generally much lower than in the case of the known compressible sorbitol types.
- the sorbitol characterized in this way has a number of advantageous tableting properties.
- a compressible sorbitol obtained by crystallization has only a bending strength of about 2.5 N / mm 2 at a pressing force of 10,000 N, which only increases to one by increasing the pressing force to 20,000 N. Value of about 5 N / mm 2 can be increased. Tableting machines with which the sorbitol according to the invention is pressed can therefore work at relatively low pressing forces and are therefore subject to much less wear.
- the abrasion resistance is particularly important for the quality of the tablets.
- Tablets pressed with the sorbitol according to the invention already have an abrasion resistance of less than 1% at a pressing force of 10,000 N, which decreases to an extremely low value of about 0.2 to 0.3% even at a pressing force of 15000 N or more.
- Tablets made from the known compressible sorbitol on the other hand, have an abrasion of more than 6% at a pressing force of 5000 N, which only decreases to a final value of about 1% above 15000 N.
- the strength of the tablets pressed from the sorbitol according to the invention with the same pressing force is very much higher than that of the tablets pressed from the known sorbitol. Tablets of the same strength can therefore be produced with the sorbitol according to the invention with a lower compression force and accordingly have a significantly higher volume than the comparison tablets. Since the sucking time corresponds to the volume of the tablet with the same tablet strength, tablets can be produced with the sorbitol according to the invention which have a significantly lower weight with the same sucking duration. In this way, considerable material savings can be achieved.
- sorbitol Due to the irregular surface of the sorbitol according to the invention is able to also larger amounts of additives such.
- the absorption capacity is significantly higher than that of the known compressible sorbitol types. Even when heavily loaded with additives, homogeneous mixtures are obtained and the compressed materials produced from them have a uniform appearance.
- water-soluble additives such as. B. dyes, vitamins and the like, to distribute completely homogeneously in sorbitol or the compressed products produced therefrom.
- tablets produced according to the invention have a completely uniformly colored surface.
- the sorbitol according to the invention can only be added with the addition of small amounts of a conventional lubricant, e.g. 0.3 to 2% magnesium stearate, can be pressed directly. It is only essential that the water content, which is about 0.3 to about 1% by weight due to the production process according to the invention, does not rise to values above about 1% due to storage for too long at high atmospheric humidity. Sorbitol types with a higher water content can still be pressed perfectly in rooms with relatively low air humidity, but tend to stick to the plungers when they are pressed in rooms with high air humidity.
- a conventional lubricant e.g. 0.3 to 2% magnesium stearate
- the degree of purity of the sorbitol according to the invention should be above about 98%, since it has been found that the tablet properties can be influenced very negatively by impurities.
- admixing mannitol in an amount of about 10 to 15% by weight before or after spray drying gives a product which already has a flexural strength of above 15,000 N reached over 15 N / mm 2 .
- a particularly advantageous aspect of the present invention is therefore also sorbitol preparations which contain up to 15% by weight of mannitol.
- the sorbitol according to the invention can be used alone or with additives for all customary purposes, in particular for the manufacture of chewable and lozenges. Due to the improved tabletting properties, the invention achieves considerable progress in this area.
- a solution of 750 g of crystallized dextrose in 500 ml of deionized water is mixed in a 2-1 high-pressure autoclave with 50 g of moist Raney nickel and hydrogenated at 130 ° C. and 150 bar until the hydrogen uptake has ended. After the suspension has cooled, the catalyst is filtered off and washed with water.
- the solids content of the solution consists of 99.2% by weight of sorbitol. By-products are only found in insignificant traces.
- the approximately 60% by weight solution thus prepared is sprayed using a centrifugal atomizer and dried with an air stream of 150 ° C.
- a sorbitol consisting essentially of the y-form with 0.8% by weight of residual moisture, a melting point of 96 ° C., a bulk density of 0.4 g / ml and a specific surface area (according to BET) of 1.0 m is obtained 2 / g, an average grain size (a 'value of the RRSB distribution) of 500 microns, with 90% of the particles in the range of 280 up to 620 ⁇ m.
- the flexural strength is measured using a modified hardness tester from Erweka, Heusenstamm, according to the P.H. List: Pharmaceutical Forms, 3rd edition, p. 105, Wiss. Verlagsgesellschaft mbH, Stuttgart, 1982, determined method described, the span being 6.7 mm.
- the friability is determined in a friabilator from Erweka, Heusenstamm, with a running time of 6 minutes.
- Example 1 It is hydrogenated according to Example 1, but at a temperature of 150 ° C.
- the solids content of the solution obtained consists of 98.7% by weight of sorbitol.
- By-products are also only available in insignificant quantities here.
- the product obtained by spray drying analogously to Example 1 can be pressed without problems, results being obtained analogously to those given in Example 1.
- Example 2 It is hydrogenated analogously to Example 1, but at a temperature of 170 ° C.
- the solids content of the solution obtained consists of only 95.9% by weight of sorbitol.
- the by-products contained make the product obtained after spray drying analogous to Example 1 unsuitable for direct pressing, although the material could easily be used as a sugar substitute.
- a solution of 750 kg of crystallized dextrose in 500 l of water is mixed with 35 kg of Raney nickel and hydrogenated at 180 ° C. and a pressure of 150 bar.
- the cooled and filtered solution after the end of the hydrogen uptake has a solids content which consists of 94.1% by weight of sorbitol.
- a sorbitol prepared according to Example 1 or Example 2 can be used in the following application examples.
- the ingredients are mixed and pressed at a pressure of 6000 N into tablets 6 mm in diameter and 100 mg in weight.
- the constituents are mixed and pressed at a pre-pressure of 14,000 N into tablets of 9 mm in diameter and a weight of 250 mg.
- the ingredients are mixed and pressed at a pressure of 8000 N to tablets of 7 mm in diameter and 100 mg in weight.
- the ingredients are mixed and pressed at a pressure of 30,000 N to tablets of 13 mm in diameter and 500 mg in weight.
- the ingredients are mixed and pressed at a pressure of 30,000 N to tablets of 13 mm in diameter and 500 mg in weight.
- the ingredients are mixed and compressed with a pressure of 30,000 N to tablets of 13 mm in diameter and a weight of 500 mg.
- the ingredients are mixed and pressed with a pressure of 30,000 N into tablets with a diameter of 13 mm and a weight of 500 mg.
- sorbitol instant sweetened with 0.1% saccharin or 0.2 aspartame or colored sorbitol instant can also be used.
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Biophysics (AREA)
- Crystallography & Structural Chemistry (AREA)
- Medicinal Preparation (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Saccharide Compounds (AREA)
- Application Of Or Painting With Fluid Materials (AREA)
- Treatments Of Macromolecular Shaped Articles (AREA)
- Compositions Of Macromolecular Compounds (AREA)
- Seasonings (AREA)
- Formation And Processing Of Food Products (AREA)
- Prostheses (AREA)
- Glass Compositions (AREA)
- Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
- Solid-Sorbent Or Filter-Aiding Compositions (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
Die Anmeldung bezieht sich auf modifizierten Sorbit mit verbesserten Tablettiereigenschaften, gekennzeichnet durch einen Schmelzpunkt von etwa 96°C, eine Schüttdichte von o,3 bis o.6 g/ml, einen γ -Sorbit- gehalt von mindestens 90%, eine Reinheit von mindestens 98%, eine spezifische Oberfläche von 0,7 bis 1,5 m²/g, eine Biegefestigkeit von mehr als 7 N/mm² bei einer Preßkraft oberhalb 10 000 N, eine Friabilität von weniger als 1 % bei einer Preßkraft ab 10 000 N, der hergestellt wird, indem durch Hydrierung von kristallisierter Glucose bei einer Temperatur unterhalb 170°C eine Sorbitlösung erhalten wird, die bei einer Temperatur von 140 bis 170°C sprühgetrocknet wird. Der dabei erhaltene Sorbit weist einen Wassergehalt von weniger als 1% auf. Der Sorbit wird verwendet zur Herstellung von verpressten Zubereitungen.The application relates to modified sorbitol with improved tableting properties, characterized by a melting point of approximately 96 ° C., a bulk density of 0.3 to 6 g / ml, a γ-sorbitol content of at least 90%, a purity of at least 98%, a specific surface area of 0.7 to 1.5 m² / g, a bending strength of more than 7 N / mm² at a pressing force above 10,000 N, a friability of less than 1% at a pressing force from 10,000 N, which is prepared by obtaining a sorbitol solution by hydrogenation of crystallized glucose at a temperature below 170 ° C, which is spray dried at a temperature of 140 to 170 ° C. The sorbitol obtained has a water content of less than 1%. Sorbitol is used for the production of pressed preparations.
Description
Die Erfindung betrifft einen modifizierten Sorbit mit verbesserten Tablettiereigenschaften.The invention relates to a modified sorbitol with improved tabletting properties.
Sorbit ist eine in großem Umfang verwendete Tablettengrundlage, die unter anderem für Kau- und Lutschtabletten benutzt wird. Der besondere Vorteil von Sorbit liegt darin, daß er im Prinzip auch zum direkten Verpressen ohne weitere Hilfs- und Zusatzstoffe geeignet ist. Gewonnen wird Sorbit in der Regel durch Hydrierung von Stärkehydrolysaten oder durch Hydrierung von Invertzucker mit anschließender Abtrennung von Mannit. In fester Form kann er sowohl durch Kristallisation als auch durch Sprühtrocknung erhalten werden.Sorbitol is a widely used tablet base that is used, among other things, for chewable and lozenges. The particular advantage of sorbitol lies in the fact that it is in principle also suitable for direct pressing without any additional auxiliaries and additives. Sorbitol is generally obtained by hydrogenating starch hydrolyzates or by hydrogenating invert sugar with subsequent separation of mannitol. In solid form, it can be obtained both by crystallization and by spray drying.
Zur Herstellung zufriedenstellender Komprimate ist solcher Sorbit in der Regel wenig geeignet. Es sind daher spezielle Verfahren entwickelt worden, um einen zur besseren Verpressung geeigneten Sorbit herzustellen. So wird in der DE-A1 3009 875 ein sehr spezielles kompliziertes Kristallisierverfahren beschrieben, nach dem ein zum Verpressen geeigneter Sorbit hergestellt werden kann. Ein anderes spezielles Kristallisierverfahren ist in der EP-Al 32288 beschrieben.Such sorbitol is generally not very suitable for producing satisfactory compressed products. Special processes have therefore been developed to produce a sorbitol suitable for better compression. For example, DE-A1 3009 875 describes a very special, complicated crystallization process by which a sorbitol suitable for pressing can be produced. Another special crystallization process is described in EP-Al 32288.
Diese Verfahren erfordern jedoch einen erheblichen technischen Aufwand, da die Kristallisationsbedingungen sehr exakt eingehalten werden müssen, um zu einem verwertbaren Produkt zu gelangen. Darüberhinaus sind die aus den so hergestellten Sorbittypen gepressten Erzeugnisse noch nicht völlig zufriedenstellend in Bezug auf Biegefestigkeit und Abriebfestigkeit.However, these processes require considerable technical effort, since the crystallization conditions must be adhered to very precisely in order to arrive at a usable product. In addition, the products pressed from the sorbitol types produced in this way are not yet completely satisfactory in terms of bending strength and abrasion resistance.
Es bestand deshalb die Aufgabe, einen Sorbit zu finden, der problemloser herstellbar ist und der insbesondere in den Tablettiereigenschaften wie Biege- und Abriebfestigkeit gegenüber den bekannten Sorbittypen verbessert ist.It was therefore the task of finding a sorbitol which can be produced more easily and which is improved in comparison with the known types of sorbitol, particularly in terms of its tableting properties, such as bending and abrasion resistance.
Es wurde nun gefunden, daß überraschenderweise auch durch Sprühtrocknung gewonnener Sorbit zur direkten Verpressung geeignet ist und dabei sogar bessere Resultate liefert als der bisher gebräuchliche durch Kristallisation gewonnene Sorbit. Voraussetzung dafür ist, daß dieser Sorbit bestimmte Spezifikationen erfüllt, bzw. beim Verfahren zur Herstellung bestimmte Parameter eingehalten werden.It has now been found that, surprisingly, sorbitol obtained by spray drying is also suitable for direct compression and in doing so even gives better results than the sorbitol obtained previously by crystallization. The prerequisite for this is that this sorbitol meets certain specifications or that certain parameters are adhered to in the production process.
Gegenstand der Erfindung ist daher ein modifizierter Sorbit mit verbesserten Tablettiereigenschaften, der gekennzeichnet ist durch
- a) einen Schmelzpunkt von 96 °C
- b) eine Schüttdichte (nach DIN 53 912) von 0,3 - 0,6 g/ml
- c) einen y-Sorbitgehalt von mindestens 90 %
- d) eine Reinheit von mindestens 98 %
- e) eine spezifische Oberfläche (nach BET) von 0,7 bis 1,5 m2/g
- f) eine Biegefestigkeit von mehr als 7 N/mm2 bei einer Preßkraft oberhalb 10000 N
- g) eine Friabilität von weniger als 1 % bei einer Preßkraft ab 10 000 N.
- a) a melting point of 96 ° C.
- b) a bulk density (according to DIN 53 912) of 0.3-0.6 g / ml
- c) a y-sorbitol content of at least 90%
- d) a purity of at least 98%
- e) a specific surface area (according to BET) of 0.7 to 1.5 m 2 / g
- f) a bending strength of more than 7 N / mm 2 with a pressing force above 10,000 N
- g) a friability of less than 1% with a pressing force of 10,000 N.
Gegenstand der Erfindung ist auch ein Verfahren zur Herstellung von Sorbit mit verbesserten Tablettiereigenschaften wobei durch Hydrierung von glucosehaltigen Lösungen eine Sorbitlösung gewonnen wird und daraus durch Sprühtrocknung Sorbit erhalten wird, das dadurch gekennzeichnet ist, daß eine Lösung von kristallisierter Glucose bei einer Temperatur unterhalb 170 °C hydriert wird und die so erhaltene Sorbitlösung bei einer Temperatur von 140 bis 170 °C so sprühgetrocknet wird, daß das erhaltene Produkt einen Wassergehalt von weniger als 1 % aufweist.The invention also relates to a process for the production of sorbitol with improved tabletting properties, a sorbitol solution being obtained by hydrogenation of glucose-containing solutions and being obtained therefrom by spray drying, which is characterized in that a solution of crystallized glucose at a temperature below 170.degree is hydrogenated and the sorbitol solution thus obtained is spray-dried at a temperature of 140 to 170 ° C so that the product obtained has a water content of less than 1%.
Schließlich ist Gegenstand der Erfindung auch die Verwendung des Sorbits zur Herstellung von verpressten Zubereitungen.Finally, the invention also relates to the use of sorbitol for the production of pressed preparations.
Es ist bekannt, durch Sprühtrocknung gewonnenen sogenannten Instant-Sorbit auch als Zusatzstoff zu festen, auch verpressten, Zubereitungen zu verwenden. Dazu konnte der bisher bekannte Instant-Sorbit jedoch nicht allein verwendet werden, sondern mußte mit kristallisiertem Sorbit, z. B. nach der DE-A1 3009875 oder dem EP-A1 32288, verschnitten werden. Die alleinige Verwendung von bisher bekanntem Instant-Sorbit führte nach kurzer Zeit zum Kleben auf der Tablettenpresse und damit zu ihrer Blockierung.It is known to use so-called instant sorbitol obtained by spray drying as an additive to solid, also compressed, preparations. However, the previously known instant sorbitol could not be used alone, but had to be mixed with crystallized sorbitol, e.g. B. be cut according to DE-A1 3009875 or EP-A1 32288. The sole use of previously known instant sorbitol soon led to sticking to the tablet press and thus to its blocking.
Es wurde jetzt jedoch gefunden, daß die Herstellung von Instant-Sorbit so gesteuert werden kann, daß ein sehr gut verpressbares Produkt erhalten wird. Eine wesentliche Voraussetzung dafür ist, daß der Sorbit weitgehend frei ist von Nebenprodukten, wie sie z. B. durch die Wahl des Ausgangsmaterials für die Hydrierung bzw. durch die Hydrierbedingungen selbst gebildet werden können. Schon geringe Mengen der isomeren Zuckeralkohole Idit, Galaktit oder Talit verhindern eine einwandfreie Verpressung und sollten daher vorzugsweise maximal in einer Menge von etwa 0,1 % enthalten sein.However, it has now been found that the production of instant sorbitol can be controlled in such a way that a very compressible product is obtained. An essential prerequisite for this is that the sorbitol is largely free of by-products such as those found in e.g. B. can be formed by the choice of the starting material for the hydrogenation or by the hydrogenation conditions themselves. Even small amounts of the isomeric sugar alcohols idit, galactite or talit prevent perfect pressing and should therefore preferably be contained in a maximum of about 0.1%.
Wesentliche Voraussetzung für die Herstellung des erfindungsgemäßen Sorbits ist daher die Verwendung einer kristallisierten Glucose als Ausgangsmaterial für die Hydrierung. Ebenso wichtig ist, daß die Hydrierung unter schonenden Bedingungen stattfindet, d. h. bei Temperaturen, die unterhalb etwa 170 °C, vorzugsweise unterhalb etwa 160 °C, liegen.An essential prerequisite for the production of the sorbitol according to the invention is the use of crystallized glucose as the starting material for the hydrogenation. It is equally important that the hydrogenation takes place under gentle conditions, i. H. at temperatures which are below approximately 170 ° C., preferably below approximately 160 ° C.
Die Hydrierung kann ansonsten unter den üblichen Bedingungen durchgeführt werden.The hydrogenation can otherwise be carried out under the usual conditions.
Dabei werden 50 bis 70 %ige Glucose-Lösungen in Gegenwart eines Hydrierkatalysators, wie z. B. eines Nickel-Trägerkatalysators, insbesondere Raney-Nickel, bei Wasserstoffdrucken von etwa 150 bis etwa 200 bar, insbesondere etwa 150 bis etwa.180 bar, hydriert. Danach wird die Lösung abgekühlt und vom Katalysator abgetrennt. Der Katalysator kann ggf. nach Aufarbeitung wieder verwendet werden. Die Analyse der Lösungen zeigt, daß bereits bei Temperaturen von 170 °C erhebliche Mengen an Nebenprodukten gebildet werden. Obwohl diese Nebenprodukte die Verwendbarkeit des Sorbits als Zuckeraustauschstoff nicht stören, hat, sich doch überraschenderweise herausgestellt, daß diese Nebenprodukte die Verpressbarkeit des Sorbits stark beeinträchtigen. Bei Hydriertemperaturen unterhalb etwa 170 °C und insbesondere unterhalb etwa 160 °C dagegen ist die Bildung von Nebenprodukten so stark vermindert, daß der Sorbit aus den so erhaltenen Sorbitlösungen nicht nach komplizierten und zeitaufwendigen Verfahren kristallisiert werden muß, sondern durch Sprühtrocknung gewonnen werden kann.50 to 70% glucose solutions in the presence of a hydrogenation catalyst, such as. B. a supported nickel catalyst, especially Raney nickel, hydrogenated at hydrogen pressures of about 150 to about 200 bar, especially about 150 to about 180 bar. The solution is then cooled and separated from the catalyst. If necessary, the catalyst can be reused after working up. The analysis of the solutions shows that considerable amounts of by-products are formed even at temperatures of 170 ° C. Although these by-products do not interfere with the usability of the sorbitol as a sugar substitute, it has surprisingly been found that these by-products greatly impair the compressibility of the sorbitol. At hydrogenation temperatures below about 170 ° C and in particular below about 160 ° C, however, the formation of by-products is so greatly reduced that the sorbitol from the sorbitol solutions thus obtained does not have to be crystallized by complicated and time-consuming processes, but can be obtained by spray drying.
Zur Sprühtrocknung kann unmittelbar die aus der Hydrierlösung nach Abtrennen des Katalysators und Entsalzung erhaltene Sorbitlösung verwendet werden. Der Feststoffgehalt wird zuvor auf etwa 65 bis etwa 75 Gew.% eingestellt. Die Versprühung wird durch Zerstäuben mittels eines Zentrifugalzerstäubers in einen auf eine Temperatur von 140 - 170 °C erwärmten trockenen zentrifugal eingeblasenen Luftstrom durchgeführt. Die Menge der zugeführten Sorbitlösung und der eingeblasenen Heißluft wird so abgestimmt, daß der Sorbit bis auf einen Wassergehalt von etwa 0,3 bis etwa 1 Gew.% getrocknet wird. Auf jeden Fall sollte der Wassergehalt unterhalb 1 Gew.% liegen.The sorbitol solution obtained from the hydrogenation solution after separating the catalyst and desalting can be used directly for spray drying. The solids content is previously adjusted to about 65 to about 75% by weight. The spraying is carried out by atomization using a centrifugal atomizer in a dry, centrifugally blown air stream heated to a temperature of 140-170 ° C. The amount of the sorbitol solution supplied and the hot air blown in are adjusted so that the sorbitol is dried to a water content of about 0.3 to about 1% by weight. In any case, the water content should be below 1% by weight.
Die Sorbitteilchen, die dabei durch Entwässerung der Sorbitlösungströpfchen erhalten werden, werden bei der Sprühtrocknung auf eine Temperatur von etwa 50 bis etwa 70 0C erwärmt, während die eingeblasene Luft auf etwa die gleiche Temperatur abgekühlt wird. Der Sorbit wird in Behältern gesammelt und ist nach dem Abkühlen direkt zur Herstellung von Komprimaten geeignet. Im Gegensatz zu dem vorbekannten Sorbit-Instant ist das nach dem erfindungsgemäßen Verfahren erhaltene Material überraschenderweise unter Zusatz von geringen Mengen eines üblichen Gleitmittels wie z.B. Magnesiumstearat verpressbar, ohne daß es zum Kleben an den Tablettierstempeln kommt.The Sorbitteilchen which are thereby obtained by dehydration of the Sorbitlösungströpfchen are heated during the spray drying to a temperature of about 50 to about 70 0 C, while the blown-in air is cooled to about the same temperature. The sorbitol is collected in containers and, after cooling, is suitable for the production of compressed products. In contrast to the previously known sorbitol instant, the material obtained by the process according to the invention can surprisingly be pressed with the addition of small amounts of a conventional lubricant, such as magnesium stearate, without sticking to the tabletting dies.
Bei dem erfindungsgemäßen Sorbit handelt es sich um einen Sorbit, der nach dem Debye-Scherrer-Diagramm im wesentlichen aus y-Sorbit besteht. Im Gegensatz zu den aus der DE-Al 3009875 und der EP-Al 32288 bekannten y-Sorbiten besitzt der erfindungsgemäße Sorbit eine unregelmäßige Oberfläche. Im Schmelzverhalten (Differential Scanning Calorimetry) zeigt der erfindungsgemäße Sorbit einen bei etwa 96 °C liegenden scharfen Peak. Die Schüttdichte (nach DIN 53 912) beträgt etwa 0,3 bis 0,6 g/ml, die Stampfdichte (nach DIN 53 194) etwa 0,4 bis 0,7 g/ml. Aufgrund der unregelmäßigen Oberfläche besitzt der erfindungsgemäße Sorbit eine relativ hohe spezifische Oberfläche von etwa 0,7 bis etwa 1,5 m2/g. Die Teilchengröße kann durch das Sprühtrockenverfahren in weiten Grenzen gesteuert werden, liegt aber in der Regel wesentlich niedriger als bei den vorbekannten verpreßbaren Sorbittypen.The sorbitol according to the invention is a sorbitol which, according to the Debye-Scherrer diagram, essentially consists of y-sorbitol. In contrast to the y-sorbitol known from DE-Al 3009875 and EP-Al 32288, the sorbitol according to the invention has an irregular surface. In the melting behavior (differential scanning calorimetry), the sorbitol according to the invention shows a sharp peak at approximately 96 ° C. The bulk density (according to DIN 53 912) is about 0.3 to 0.6 g / ml, the tamped density (according to DIN 53 194) is about 0.4 to 0.7 g / ml. Because of the irregular surface, the sorbitol according to the invention has a relatively high specific surface area of approximately 0.7 to approximately 1.5 m 2 / g. The particle size can be controlled within wide limits by the spray drying process, but is generally much lower than in the case of the known compressible sorbitol types.
Der so charakterisierte Sorbit besitzt eine Reihe von vorteilhaften Tablettiereigenschaften.The sorbitol characterized in this way has a number of advantageous tableting properties.
Überraschenderweise kann festgestellt werden, daß mit dem erfindungsgemäßen Sorbit bei gleicher Preßkraft sehr viel härtere Tabletten hergestellt werden können, als mit den bekannten verpressbaren Sorbittypen. Da die optimale Festigkeit von Lutschtabletten durch das Lutschverhalten vorgegeben ist, bedeutet dies, daß optimal harte Tabletten bereits mit sehr niedrigen Preßkräften hergestellt werden können. Die Biegefestigkeit als Maßstab für die Härte erreicht beim erfindungsgemäßen Sorbit bei Tabletten von 10 mm Durchmesser und 0,3 g Gewicht bereits bei einer Preßkraft ab etwa 10000 N einen Wert von etwa 7 N/mm2 und steigt weiter an auf einen Wert von etwa 11 N/mm2 bei einer Preßkraft von oberhalb 20000 N. Ein durch Kristallisation gewonnener verpressbarer Sorbit hat dagegen bei einer Preßkraft von 10000 N nur eine Biegefestigkeit von etwa 2,5 N/mm2, die durch Erhöhung der Preßkraft auf 20000 N lediglich auf einen Wert von etwa 5 N/mm2 gesteigert werden kann. Tablettiermaschinen, mit denen der erfindungsgemäße Sorbit verpreßt wird, können also bei relativ niedrigen Presskräften arbeiten und unterliegen auf diese Weise einem sehr viel geringeren Verschleiß.Surprisingly, it can be established that much harder tablets can be produced with the sorbitol according to the invention with the same pressing force than with the known compressible sorbitol types. Since the optimal strength of lozenges is determined by the sucking behavior, this means that optimally hard tablets can be manufactured with very low compression forces. The bending strength as a measure of the hardness in the sorbitol according to the invention for tablets with a diameter of 10 mm and 0.3 g weight already reaches a value of about 7 N / mm 2 with a pressing force of about 10,000 N and continues to increase to a value of about 11 N / mm 2 at a pressing force of above 20,000 N. A compressible sorbitol obtained by crystallization, on the other hand, has only a bending strength of about 2.5 N / mm 2 at a pressing force of 10,000 N, which only increases to one by increasing the pressing force to 20,000 N. Value of about 5 N / mm 2 can be increased. Tableting machines with which the sorbitol according to the invention is pressed can therefore work at relatively low pressing forces and are therefore subject to much less wear.
Neben der Biegefestigkeit ist insbesondere auch die Abriebfestigkeit entscheidend für die Qualität der Tabletten. Mit dem erfindungsgemäßen Sorbit gepresste Tabletten besitzen bereits bei einer Preßkraft von 10000 N eine Abriebfestigkeit von weniger als 1 %, die bereits bei einer Preßkraft ab 15000 N auf einen extrem geringen Wert von etwa 0,2 bis 0,3 % zurückgeht. Tabletten aus dem bekannten verpreßbaren Sorbit dagegen haben bei 5000 N Preßkraft einen Abrieb von mehr als 6 %, der erst oberhalb 15000 N auf einen Endwert von etwa 1 % zurückgeht.In addition to the flexural strength, the abrasion resistance is particularly important for the quality of the tablets. Tablets pressed with the sorbitol according to the invention already have an abrasion resistance of less than 1% at a pressing force of 10,000 N, which decreases to an extremely low value of about 0.2 to 0.3% even at a pressing force of 15000 N or more. Tablets made from the known compressible sorbitol, on the other hand, have an abrasion of more than 6% at a pressing force of 5000 N, which only decreases to a final value of about 1% above 15000 N.
Wie bereits oben erwähnt, ist die Festigkeit der aus dem erfindungsgemäßen Sorbit gepreßten Tabletten bei gleicher Preßkraft sehr viel höher als die aus dem bekannten Sorbit gepreßten Tabletten. Tabletten gleicher Festigkeit können daher mit dem erfindungsgemäßen Sorbit bei geringerer Preßkraft hergestellt werden und besitzen demgemäß ein deutlich höheres Volumen als die Vergleichstabletten. Da bei gleicher Tablettenfestigkeit die Lutschdauer dem Volumen der Tablette entspricht, können mit dem erfindungsgemäßen Sorbit Tabletten hergestellt werden, die bei gleicher Lutschdauer ein wesentlich geringeres Gewicht aufweisen. Auf diese Weise können erhebliche Materialeinsparungen erzielt werden.As already mentioned above, the strength of the tablets pressed from the sorbitol according to the invention with the same pressing force is very much higher than that of the tablets pressed from the known sorbitol. Tablets of the same strength can therefore be produced with the sorbitol according to the invention with a lower compression force and accordingly have a significantly higher volume than the comparison tablets. Since the sucking time corresponds to the volume of the tablet with the same tablet strength, tablets can be produced with the sorbitol according to the invention which have a significantly lower weight with the same sucking duration. In this way, considerable material savings can be achieved.
Durch die unregelmäßige Oberfläche ist der erfindungsgemäße Sorbit in der Lage, auch größere Mengen von Zusatzstoffen, wie z. B. von Kakaopulver, Farbstoffen oder anderen Zusätzen zu binden. Die Aufnahmekapazität liegt dabei wesentlich über dem der bekannten verpressbaren Sorbittypen. Auch bei starker Beladung mit Zusatzstoffen erhält man homogene Mischungen und die daraus hergestellten Komprimate besitzen ein gleichmäßiges Aussehen.Due to the irregular surface of the sorbitol according to the invention is able to also larger amounts of additives such. B. of cocoa powder, dyes or other additives. The absorption capacity is significantly higher than that of the known compressible sorbitol types. Even when heavily loaded with additives, homogeneous mixtures are obtained and the compressed materials produced from them have a uniform appearance.
Aufgrund der besonderen Herstellungsart durch Versprühen einer wässerigen Lösung ist es möglich; wasserlösliche Zusätze, wie z. B. Farbstoffe, Vitamine und dergleichen, völlig homogen in Sorbit bzw. den daraus hergestellten Komprimaten zu verteilen.Due to the special production method by spraying an aqueous solution, it is possible; water-soluble additives, such as. B. dyes, vitamins and the like, to distribute completely homogeneously in sorbitol or the compressed products produced therefrom.
Im Gegensatz zu Tabletten, die durch Zumischen von Farbstoff zu kristallisiertem Sorbit vor der Tablettierung erhalten wurden, und die eine gesprenkelte Oberfläche zeigen, besitzen erfindungsgemäß hergestellte Tabletten eine vollkommen gleichmäßig gefärbte Oberfläche.In contrast to tablets which were obtained by admixing dye to crystallized sorbitol before tabletting and which have a mottled surface, tablets produced according to the invention have a completely uniformly colored surface.
Wie bereits erwähnt, kann der erfindungsgemäße Sorbit lediglich unter Zusatz von geringen Mengen eines üblichen Gleitmittels, wie z.B. 0,3 bis 2 % Magnesiumstearat, direkt verpreßt werden. Wesentlich dafür ist lediglich, daß der Wassergehalt, der aufgrund des erfindungsgemäßen Herstellungsverfahrens bei etwa 0,3 bis etwa 1 Gew.% liegt, nicht durch zu langes Lagern bei hoher Luftfeuchtigkeit auf Werte über etwa 1 % ansteigt. Sorbittypen mit höherem Wassergehalt können zwar in Räumen mit relativ niedriger Luftfeuchtigkeit noch einwandfrei verpreßt werden, neigen jedoch beim Verpressen in Räumen mit hoher Luftfeuchtigkeit zum Ankleben an den Preßstempeln.As already mentioned, the sorbitol according to the invention can only be added with the addition of small amounts of a conventional lubricant, e.g. 0.3 to 2% magnesium stearate, can be pressed directly. It is only essential that the water content, which is about 0.3 to about 1% by weight due to the production process according to the invention, does not rise to values above about 1% due to storage for too long at high atmospheric humidity. Sorbitol types with a higher water content can still be pressed perfectly in rooms with relatively low air humidity, but tend to stick to the plungers when they are pressed in rooms with high air humidity.
Diese gute Verpreßbarkeit wird auch nicht beeinträchtigt, wenn Zusatzstoffe wie z. B. Farbstoffe, Geschmacksstoffe oder pharmazeutische Wirkstoffe zugemischt werden, durch die Aussehen, Geschmack und Wirkungsspektrum der Zubereitung beeinflußt werden können.This good compressibility is not affected if additives such as. B. colorants, flavors or pharmaceutical active ingredients can be mixed through the appearance, taste and spectrum of activity of the preparation can be influenced.
Wie bereits oben erwähnt, sollte der Reinheitsgrad des erfindungsgemäßen Sorbits oberhalb von etwa 98 % liegen, da festgestellt wurde, daß durch Verunreinigungen die Tablettiereigenschaften sehr negativ beeinflußt werden können.As already mentioned above, the degree of purity of the sorbitol according to the invention should be above about 98%, since it has been found that the tablet properties can be influenced very negatively by impurities.
Andererseits wurde jedoch festgestellt, daB durch bestimmte Zumischungen, die ohnehin schon sehr gute Tablettenfestigkeit sogar noch erhöht werden kann. So wird überraschenderweise durch Zumischen von Mannit in einer Menge von etwa 10 bis 15 Gew.% vor oder nach dem Sprühtrocknen ein Produkt erhalten, das bereits bei einer Preßkraft von oberhalb 15000 N eine Biegefestigkeit von über 15 N/mm2 erreicht. Ein besonders vorteilhafter Aspekt der vorliegenden Erfindung sind daher auch Sorbitzubereitungen, die bis zu 15 Gew.% Mannit enthalten.On the other hand, however, it was found that certain admixtures can increase the tablet strength, which is already very good anyway. Surprisingly, admixing mannitol in an amount of about 10 to 15% by weight before or after spray drying gives a product which already has a flexural strength of above 15,000 N reached over 15 N / mm 2 . A particularly advantageous aspect of the present invention is therefore also sorbitol preparations which contain up to 15% by weight of mannitol.
Der erfindungsgemäße Sorbit kann allein oder mit Zusätzen zu allen üblichen Zwecken eingesetzt werden, insbesondere zur Herstellung von Kau- und Lutschtabletten. Durch die verbesserten Tablettiereigenschaften wird durch die Erfindung ein erheblicher Fortschritt auf diesem Gebiet erzielt.The sorbitol according to the invention can be used alone or with additives for all customary purposes, in particular for the manufacture of chewable and lozenges. Due to the improved tabletting properties, the invention achieves considerable progress in this area.
Herstellungsbeispiele:Manufacturing examples:
Eine Lösung von 750 g kristallisierter Dextrose in 500 ml vollentsalztem Wasser wird in.einem 2-1-Hochdruckautoklaven mit 50 g feuchtem Raney-Nickel versetzt und bei 130 °C und 150 bar bis zur Beendigung der Wasserstoffaufnahme hydriert. Nach Abkühlen der Suspension wird der Katalysator abgesaugt und mit Wasser gewaschen.A solution of 750 g of crystallized dextrose in 500 ml of deionized water is mixed in a 2-1 high-pressure autoclave with 50 g of moist Raney nickel and hydrogenated at 130 ° C. and 150 bar until the hydrogen uptake has ended. After the suspension has cooled, the catalyst is filtered off and washed with water.
Der Feststoffgehalt der Lösung besteht zu 99,2 Gew.% aus Sorbit. Nebenprodukte sind nur in unbedeutenden Spuren enthalten. Die so hergestellte etwa 60 Gew.%ige Lösung wird mittels eines Zentrifugalzerstäubers versprüht und mit einem Luftstrom von 150 °C getrocknet. Man erhält einen im wesentlichen aus der y-Form bestehenden Sorbit mit 0,8 Gew.% Restfeuchtigkeit, einem Schmelzpunkt von 96 °C, einer Schüttdichte von 0,4 g/ml, einer spezifischen Oberfläche (nach BET) von 1,0 m2/g, einer mittleren Korngröße (a'-Wert der RRSB-Verteilung) von 500 µm, wobei 90 % der Teilchen im Bereich von 280 bis 620 µm liegen. Beim Pressen des Sorbits unter Zusatz von 0,3 Gew.% Magnesiumstearat zu Tabletten mit 300 mg Gewicht und 10 mm Durchmesser auf einer Exzenterpresse werden folgende Ergebnisse erzielt:
Die Biegefestigkeit wird mit einem umgebauten Härtetester der Firma Erweka, Heusenstamm, nach der in P.H. List: Arzneiformenlehre, 3. Auflage, S. 105, Wiss. Verlagsgesellschaft mbH, Stuttgart, 1982, beschriebenen Methode bestimmt, wobei die Stützweite 6,7 mm beträgt.The flexural strength is measured using a modified hardness tester from Erweka, Heusenstamm, according to the P.H. List: Pharmaceutical Forms, 3rd edition, p. 105, Wiss. Verlagsgesellschaft mbH, Stuttgart, 1982, determined method described, the span being 6.7 mm.
Die Friabilität wird in einem Friabilator der Firma Erweka, Heusenstamm, bei einer Laufzeit von 6 Min. bestimmt.The friability is determined in a friabilator from Erweka, Heusenstamm, with a running time of 6 minutes.
Es wird entsprechend Beispiel 1 hydriert, jedoch bei einer Temperatur von 150 °C. Der Feststoffgehalt der erhaltenen Lösung besteht zu 98,7 Gew.% aus Sorbit. Auch hier sind Nebenprodukte nur in unbedeutender Menge vorhanden. Das durch Sprühtrocknung analog Beispiel 1 erhaltene Produkt läßt sich problemlos verpressen, wobei Ergebnisse analog den in Beispiel 1 angegebenen erzielt werden.It is hydrogenated according to Example 1, but at a temperature of 150 ° C. The solids content of the solution obtained consists of 98.7% by weight of sorbitol. By-products are also only available in insignificant quantities here. The product obtained by spray drying analogously to Example 1 can be pressed without problems, results being obtained analogously to those given in Example 1.
Es wird analog Beispiel 1, jedoch bei einer Temperatur von 170 °C hydriert. Der Feststoffgehalt der erhaltenen Lösung besteht nur zu 95,9 Gew.% aus Sorbit. Die enthaltenen Nebenprodukte machen das nach Sprühtrocknung analog Beispiel 1 gewonnene Produkt untauglich für die direkte Verpressung, obwohl das Material ohne weiteres als Zuckeraustauschstoff eingesetzt werden könnte.It is hydrogenated analogously to Example 1, but at a temperature of 170 ° C. The solids content of the solution obtained consists of only 95.9% by weight of sorbitol. The by-products contained make the product obtained after spray drying analogous to Example 1 unsuitable for direct pressing, although the material could easily be used as a sugar substitute.
Eine Lösung von 750 kg kristallisierter Dextrose in 500 1 Wasser wird mit 35 kg Raney-Nickel versetzt und bei 180 °C und einem Druck von 150 bar hydriert. Die nach Beendigung der Wasserstoffaufnahme abgekühlte und filtrierte Lösung weist einen Feststoffgehalt auf, der zu 94,1 Gew.% aus Sorbit besteht.A solution of 750 kg of crystallized dextrose in 500 l of water is mixed with 35 kg of Raney nickel and hydrogenated at 180 ° C. and a pressure of 150 bar. The cooled and filtered solution after the end of the hydrogen uptake has a solids content which consists of 94.1% by weight of sorbitol.
Die zahlreichen Nebenprodukte machen das durch Sprühtrocknung analog Beispiel 1 gewonnene Produkt untauglich für die direkte Verpressung, obwohl auch dieses Produkt als Zuckeraustauschstoff gut verwendbar wäre.The numerous by-products make the product obtained by spray drying analogous to Example 1 unsuitable for direct pressing, although this product could also be used as a sugar substitute.
In den folgenden Anwendungsbeispielen kann ein nach Beispiel 1 oder Beispiel 2 hergestellter Sorbit eingesetzt werden.A sorbitol prepared according to Example 1 or Example 2 can be used in the following application examples.
In sämtlichen angegebenen Rezepturen kann auch mit 0,1 % Saccharin oder 0,2 Aspartam aufgesüßter Sorbit-Instant oder auch eingefärbter Sorbit-Instant eingesetzt werden.In all the recipes given, sorbitol instant sweetened with 0.1% saccharin or 0.2 aspartame or colored sorbitol instant can also be used.
Claims (3)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AT83111682T ATE47830T1 (en) | 1982-12-07 | 1983-11-23 | IMPROVED SORBITOL, METHOD OF MANUFACTURE AND USE. |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19823245170 DE3245170A1 (en) | 1982-12-07 | 1982-12-07 | IMPROVED SORBITE, METHOD FOR THE PRODUCTION AND USE |
DE3245170 | 1982-12-07 |
Publications (3)
Publication Number | Publication Date |
---|---|
EP0111209A2 true EP0111209A2 (en) | 1984-06-20 |
EP0111209A3 EP0111209A3 (en) | 1986-03-26 |
EP0111209B1 EP0111209B1 (en) | 1989-11-08 |
Family
ID=6179970
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP83111682A Expired EP0111209B1 (en) | 1982-12-07 | 1983-11-23 | Sorbit, process for its preparation and its use |
Country Status (10)
Country | Link |
---|---|
US (2) | US4507511A (en) |
EP (1) | EP0111209B1 (en) |
JP (1) | JPS59118058A (en) |
AT (1) | ATE47830T1 (en) |
AU (1) | AU565326B2 (en) |
CA (1) | CA1202331A (en) |
DD (1) | DD215079A5 (en) |
DE (2) | DE3245170A1 (en) |
ES (1) | ES8501961A1 (en) |
FI (1) | FI79093C (en) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2613619A1 (en) * | 1987-04-07 | 1988-10-14 | Rech Inf Pharmacie | MEDICAMENTS, DIETETIC PRODUCTS OR HYGIENE PRODUCTS IN THE FORM OF PULVERULENT COMPOSITIONS OBTAINED BY ADSORPTION OF ACTIVE INGREDIENTS ON RAPID DISSOLUTION SUGAR |
FR2622190A1 (en) * | 1986-08-01 | 1989-04-28 | Deutsches Hydrierwerk Robleben | |
EP0380219A2 (en) * | 1989-01-24 | 1990-08-01 | SPI POLYOLS, Inc. | Cryoprotectant sorbitol crystal spherules |
WO1996014282A1 (en) * | 1994-11-08 | 1996-05-17 | Merck Patent Gmbh | Polyol composition produced by co-spray-drying |
WO2005123640A1 (en) * | 2004-06-17 | 2005-12-29 | Cargill, Incorporated | Steam agglomeration of polyols |
Families Citing this family (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2571046B1 (en) * | 1984-10-03 | 1987-10-16 | Roquette Freres | PROCESS FOR THE PREPARATION OF DIRECTLY COMPRESSIBLE GRANULAR MANNITOL |
FR2571045B1 (en) * | 1984-10-03 | 1987-12-11 | Roquette Freres | DIRECTLY COMPRESSIBLE GRANULAR MANNITOL AND MANUFACTURING METHOD THEREOF |
DE3541302A1 (en) * | 1985-11-22 | 1987-05-27 | Merck Patent Gmbh | SWEETENER |
US4959226A (en) * | 1987-03-16 | 1990-09-25 | Wm. Wrigley Jr. Company | Method of optimizing texture and processability of chewing gums and compositions made therefrom |
US4803083A (en) * | 1987-03-16 | 1989-02-07 | Wm. Wrigley Jr. Company | Method of optimizing texture and processability of chewing gums and compositions made therefrom |
US5023092A (en) * | 1988-06-16 | 1991-06-11 | Ici Americas Inc. | Mannitol having gamma sorbitol polymorph |
CA2029069A1 (en) * | 1989-11-07 | 1991-05-08 | Mansukh M. Patel | Chewing gum with improved sweetness profile incorporating finely ground bulk sweetener without starch |
JP2577698B2 (en) * | 1993-08-05 | 1997-02-05 | 信道 中野 | Method for producing sorbitol powder having high fluidity |
EP0820237A4 (en) * | 1995-01-25 | 1999-01-20 | Wrigley W M Jun Co | Improved rolling compound and methods of manufacturing chewing gum using same |
US6235947B1 (en) | 1997-04-14 | 2001-05-22 | Takeda Chemical Industries, Ltd. | D-mannitol and its preparation |
PL329614A1 (en) | 1996-04-16 | 1999-03-29 | Bayer Ag | D-mannitoll and method of obtaining same |
DE19615418A1 (en) * | 1996-04-22 | 1997-10-23 | Merck Patent Gmbh | Polyol composition |
DE19629640C1 (en) * | 1996-07-23 | 1997-08-28 | Metallgesellschaft Ag | Production of crystalline D-sorbitol with high gamma-content |
US5939091A (en) * | 1997-05-20 | 1999-08-17 | Warner Lambert Company | Method for making fast-melt tablets |
DE19848200A1 (en) * | 1998-10-20 | 2000-04-27 | Basf Ag | Drying phenoxymethylbenzoic acid derivatives comprises heating at a temperature above their melting point and under the same temperature and pressure as during synthesis |
FR2787110B1 (en) * | 1998-12-11 | 2001-02-16 | Roquette Freres | SORBITOL PULVERULENT AND PROCESS FOR THE PREPARATION THEREOF |
US7118765B2 (en) * | 2001-12-17 | 2006-10-10 | Spi Pharma, Inc. | Co-processed carbohydrate system as a quick-dissolve matrix for solid dosage forms |
DE10249336B9 (en) * | 2002-10-22 | 2006-12-14 | Dhw Deutsche Hydrierwerke Gmbh Rodleben | Process for the preparation of spray-dried sorbitol and drying of the sorbitol particles on a downstream fluidized bed and spray-dried sorbitol |
US20040109889A1 (en) * | 2002-12-04 | 2004-06-10 | Bunick Frank J. | Surface treatment composition for soft substrates |
JP4736509B2 (en) * | 2005-03-31 | 2011-07-27 | 小林製薬株式会社 | Candy |
JP4955974B2 (en) * | 2005-09-30 | 2012-06-20 | 小林製薬株式会社 | Candy |
EP1970053A1 (en) * | 2007-03-14 | 2008-09-17 | Boehringer Ingelheim Pharma GmbH & Co. KG | Pharmaceutical composition |
US8617588B2 (en) | 2009-03-09 | 2013-12-31 | Spi Pharma, Inc. | Highly compactable and durable direct compression excipients and excipient systems |
EP2451447B1 (en) * | 2009-07-10 | 2017-10-11 | Merck Patent GmbH | Tableting agent having a low water content, and method for the production thereof |
BE1022099B1 (en) * | 2014-01-17 | 2016-02-16 | Syral Belgium Nv | Process for preparing a high-purity syrup-rich syrup |
FR3023128B1 (en) * | 2014-07-01 | 2017-11-10 | Roquette Freres | NEW SWEETENING COMPOSITION |
KR102065863B1 (en) * | 2015-09-11 | 2020-01-13 | 아처 다니엘 미드랜드 캄파니 | Method for producing isoidide |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DD35860A (en) * | ||||
FR1040994A (en) * | 1950-08-17 | 1953-10-20 | Basf Ag | Process for the catalytic hydrogenation of sugars |
DE1941956A1 (en) * | 1968-09-17 | 1970-03-26 | Hydrierwerk Rodleben Veb | Recovery of dry sorbitol from concentrated aqueous - sorbitol solutions or sorbitol melts |
DE2059246A1 (en) * | 1969-12-16 | 1971-07-01 | Towa Kasei Kogyo Kk | Process for the production of crystalline sorbitol in the form of granules |
FR2451357A1 (en) * | 1979-03-16 | 1980-10-10 | Roquette Freres | PROCESS FOR THE COMPRESSED FORMATION OF SORBITOL AND RESULTING PRODUCT |
EP0032288A1 (en) * | 1979-12-20 | 1981-07-22 | Ici Americas Inc. | Improved gamma-sorbitol polymorph and uses thereof |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2280975A (en) * | 1938-08-17 | 1942-04-28 | Atlas Powder Co | Hydrogenation of invertible saccharides |
NL302696A (en) * | 1962-12-31 | |||
US3308171A (en) * | 1964-07-17 | 1967-03-07 | Yokohama Seito Kabushiki Kaish | Method for producing granular or powdery sorbitol from sorbitol solution |
US3484492A (en) * | 1967-02-27 | 1969-12-16 | Atlas Chem Ind | Crystallization of mannitol from sorbitol |
DK133603B (en) * | 1968-02-05 | 1976-06-14 | Kroyer K K K | Method and apparatus for recovering a dry free-flowing product from a solution or slurry of difficult-to-crystallize carbohydrates or similar alcohols. |
JPS51108005A (en) * | 1975-03-19 | 1976-09-25 | Setsu Hiraiwa | Sorubitooruno zoryuhoho |
US4292451A (en) * | 1978-03-30 | 1981-09-29 | Ici Americas Inc. | High mannitol process (alkaline hydrogenation in presence of alkali metal carbonate) |
US4293570A (en) * | 1979-04-02 | 1981-10-06 | Chimicasa Gmbh | Process for the preparation of sweetener containing product |
US4380680A (en) * | 1982-05-21 | 1983-04-19 | Uop Inc. | Method for hydrogenating aqueous solutions of carbohydrates |
-
1982
- 1982-12-07 DE DE19823245170 patent/DE3245170A1/en not_active Ceased
-
1983
- 1983-10-19 AU AU20299/83A patent/AU565326B2/en not_active Ceased
- 1983-11-23 EP EP83111682A patent/EP0111209B1/en not_active Expired
- 1983-11-23 DE DE8383111682T patent/DE3380812D1/en not_active Expired
- 1983-11-23 AT AT83111682T patent/ATE47830T1/en not_active IP Right Cessation
- 1983-12-05 CA CA000442531A patent/CA1202331A/en not_active Expired
- 1983-12-05 FI FI834450A patent/FI79093C/en not_active IP Right Cessation
- 1983-12-06 ES ES527845A patent/ES8501961A1/en not_active Expired
- 1983-12-06 DD DD83257560A patent/DD215079A5/en not_active IP Right Cessation
- 1983-12-07 JP JP58229976A patent/JPS59118058A/en active Granted
- 1983-12-07 US US06/558,865 patent/US4507511A/en not_active Expired - Fee Related
-
1985
- 1985-01-23 US US06/694,184 patent/US4605794A/en not_active Expired - Fee Related
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DD35860A (en) * | ||||
FR1040994A (en) * | 1950-08-17 | 1953-10-20 | Basf Ag | Process for the catalytic hydrogenation of sugars |
DE1941956A1 (en) * | 1968-09-17 | 1970-03-26 | Hydrierwerk Rodleben Veb | Recovery of dry sorbitol from concentrated aqueous - sorbitol solutions or sorbitol melts |
DE2059246A1 (en) * | 1969-12-16 | 1971-07-01 | Towa Kasei Kogyo Kk | Process for the production of crystalline sorbitol in the form of granules |
FR2451357A1 (en) * | 1979-03-16 | 1980-10-10 | Roquette Freres | PROCESS FOR THE COMPRESSED FORMATION OF SORBITOL AND RESULTING PRODUCT |
EP0032288A1 (en) * | 1979-12-20 | 1981-07-22 | Ici Americas Inc. | Improved gamma-sorbitol polymorph and uses thereof |
Non-Patent Citations (6)
Title |
---|
Chem. Ing. Tech., 52 (1980), Nr. 7, Seite 584 * |
CHEMICAL ABSTRACTS, Band 100, Nr. 2, 9. Januar 1984, Zusammenfassung Nr. 12550a, Columbus, Ohio (US); P.C. SCHMIDT: "Tableting characteristics of sorbitol." & PHARM. TECHNOL. 1983, 7(11), 65-6,68,70,72,74 * |
Fachbereichstandard DDR, TGL 38206, Dezember 1981 * |
NeosorbR for direct Compression (Roquette Frères), Herausgegeben vor 1981, Seiten 5 und 6 * |
Prospekt über "Sorbit"/DHW Rodleben (1982) * |
Sorbit in der Medizin und Pharmazie, Deutsche Maizena Weke GmbH, 2 Hamburg 1- Maizenahaus (1966), Seite 10 * |
Cited By (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2622190A1 (en) * | 1986-08-01 | 1989-04-28 | Deutsches Hydrierwerk Robleben | |
FR2613619A1 (en) * | 1987-04-07 | 1988-10-14 | Rech Inf Pharmacie | MEDICAMENTS, DIETETIC PRODUCTS OR HYGIENE PRODUCTS IN THE FORM OF PULVERULENT COMPOSITIONS OBTAINED BY ADSORPTION OF ACTIVE INGREDIENTS ON RAPID DISSOLUTION SUGAR |
EP0287488A1 (en) * | 1987-04-07 | 1988-10-19 | Recherche Informatique Et Pharmacie R.I.Ph., Sarl | Medicament, dietary product and hygienic product in the form of a powdery composition obtained by adsorption of the active agents on a rapidly dissolving sugar, and process for the preparation of this composition |
US4985252A (en) * | 1987-04-07 | 1991-01-15 | R. I. Ph. Recherche Informatique Et Pharmacie (S.A.R.L.) | Medication, dietetic product and hygienic product in the form of a powered composition obtained by adsorption of active ingredients on a rapidly dissolving sugar and process for obtaining said composition |
EP0380219A2 (en) * | 1989-01-24 | 1990-08-01 | SPI POLYOLS, Inc. | Cryoprotectant sorbitol crystal spherules |
EP0380219A3 (en) * | 1989-01-24 | 1991-01-16 | SPI POLYOLS, Inc. | Cryoprotectant sorbitol crystal spherules |
US5324751A (en) * | 1989-01-24 | 1994-06-28 | Ici Americas Inc. | Cryoprotectant sorbitol crystal spherules |
WO1996014282A1 (en) * | 1994-11-08 | 1996-05-17 | Merck Patent Gmbh | Polyol composition produced by co-spray-drying |
WO2005123640A1 (en) * | 2004-06-17 | 2005-12-29 | Cargill, Incorporated | Steam agglomeration of polyols |
AU2005254167B2 (en) * | 2004-06-17 | 2011-10-06 | Cargill Inc. | Steam agglomeration of polyols |
Also Published As
Publication number | Publication date |
---|---|
DE3245170A1 (en) | 1984-06-07 |
ATE47830T1 (en) | 1989-11-15 |
EP0111209A3 (en) | 1986-03-26 |
EP0111209B1 (en) | 1989-11-08 |
JPS59118058A (en) | 1984-07-07 |
DD215079A5 (en) | 1984-10-31 |
DE3380812D1 (en) | 1989-12-14 |
FI79093C (en) | 1990-05-31 |
AU565326B2 (en) | 1987-09-10 |
CA1202331A (en) | 1986-03-25 |
ES527845A0 (en) | 1984-12-16 |
JPH051247B2 (en) | 1993-01-07 |
US4605794A (en) | 1986-08-12 |
FI79093B (en) | 1989-07-31 |
FI834450A (en) | 1984-06-08 |
US4507511A (en) | 1985-03-26 |
ES8501961A1 (en) | 1984-12-16 |
AU2029983A (en) | 1984-06-14 |
FI834450A0 (en) | 1983-12-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0111209B1 (en) | Sorbit, process for its preparation and its use | |
EP0896528B1 (en) | Polyol composition | |
EP0738252B1 (en) | Polyol composition produced by co-spray-drying | |
DE3506276C1 (en) | Direct tableting | |
DE69508263T2 (en) | THERAPEUTIC MIXTURE OF VITAMIN AND CALCIUM IN THE FORM OF A GALENIAN INDIVIDUAL DOSAGE TABLET, METHOD FOR THE PRODUCTION THEREOF AND THEIR USE | |
DE19617487A1 (en) | Taste improvement of active pharmaceutical ingredients | |
CH646035A5 (en) | METHOD FOR PRODUCING DIABETIC BAKERY PRODUCTS. | |
DE69907119T3 (en) | Powdered sorbitol and its method of preparation | |
DE2706660A1 (en) | GRANULATES CONTAINING ASCORBIC ACID AND THE PROCESS FOR THEIR MANUFACTURING | |
DE19510130C1 (en) | Process for the preparation of free-flowing R, S-thioctic acid, R, S-thioctic acid and their use | |
DE69206031T2 (en) | Tableting aid. | |
DE2462081C3 (en) | Pilocarpine pamoate, process for its production and medical product containing it | |
DE3150557C2 (en) | ||
DE19845339A1 (en) | Directly compressible tabletting aid | |
EP2451446B1 (en) | Composition for the production of tablets, and method for the production of said composition | |
DE69903141T2 (en) | LACTITOL CRYSTALLIZATION, LACTITOL CRYSTALLINE AND ITS APPLICATION | |
DE3942131C2 (en) | Pharmaceutical preparation containing trimebutin with prolonged release of active ingredient and process for its preparation | |
EP0497177B1 (en) | Vitamin containing formulations and their production | |
DE2061800C3 (en) | Process for the production of a directly compressible, tricalcium phosphate-containing particulate carrier for tablet production and its use | |
EP0268813B1 (en) | Process for the preparation of a compressible granulate from celiprolol hydrochloride, free of binders | |
DE20216314U1 (en) | Pure, free-flowing, spray-dried xylitol powder with rough surface structure, useful for production of binder-free tablets for use in the pharmaceutical or food industry | |
DE2519714C3 (en) | Direct tablettable particulate carrier mass containing tricalcium phosphate and carubine | |
EP1424319B1 (en) | Spray-dried xylitol and process for its production | |
EP0098475A2 (en) | Pharmaceutical composition, its manufacture and use | |
DE3306012A1 (en) | Process for the production of free-flowing paracetamol granules |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
AK | Designated contracting states |
Designated state(s): AT CH DE FR GB IT LI NL |
|
17P | Request for examination filed |
Effective date: 19850613 |
|
PUAL | Search report despatched |
Free format text: ORIGINAL CODE: 0009013 |
|
AK | Designated contracting states |
Kind code of ref document: A3 Designated state(s): AT CH DE FR GB IT LI NL |
|
D17P | Request for examination filed (deleted) | ||
R17P | Request for examination filed (corrected) |
Effective date: 19860802 |
|
17Q | First examination report despatched |
Effective date: 19871230 |
|
ITF | It: translation for a ep patent filed | ||
GRAA | (expected) grant |
Free format text: ORIGINAL CODE: 0009210 |
|
AK | Designated contracting states |
Kind code of ref document: B1 Designated state(s): AT CH DE FR GB IT LI NL |
|
REF | Corresponds to: |
Ref document number: 47830 Country of ref document: AT Date of ref document: 19891115 Kind code of ref document: T |
|
GBT | Gb: translation of ep patent filed (gb section 77(6)(a)/1977) | ||
REF | Corresponds to: |
Ref document number: 3380812 Country of ref document: DE Date of ref document: 19891214 |
|
ET | Fr: translation filed | ||
PLBI | Opposition filed |
Free format text: ORIGINAL CODE: 0009260 |
|
PLBI | Opposition filed |
Free format text: ORIGINAL CODE: 0009260 |
|
26 | Opposition filed |
Opponent name: ROQUETTE FRERES, S.A. Effective date: 19900807 |
|
26 | Opposition filed |
Opponent name: DEUTSCHE HYDRIERWERKE GMBH RODLEBEN (I.G.) Effective date: 19900808 Opponent name: CERESTAR HOLDING B.V. Effective date: 19900808 Opponent name: ROQUETTE FRERES, S.A. Effective date: 19900807 |
|
NLR1 | Nl: opposition has been filed with the epo |
Opponent name: ROQUETTE FRERES, S.A. |
|
NLR1 | Nl: opposition has been filed with the epo |
Opponent name: DEUTSCHE HYDRIERWERKE GMBH RODLEBEN ( I.G.) Opponent name: CERESTAR HOLDING B.V. |
|
ITTA | It: last paid annual fee | ||
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: AT Payment date: 19921019 Year of fee payment: 10 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: FR Payment date: 19921109 Year of fee payment: 10 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: GB Payment date: 19921116 Year of fee payment: 10 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: CH Payment date: 19921125 Year of fee payment: 10 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: NL Payment date: 19921130 Year of fee payment: 10 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: DE Payment date: 19921212 Year of fee payment: 10 |
|
RDAG | Patent revoked |
Free format text: ORIGINAL CODE: 0009271 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: PATENT REVOKED |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: PL |
|
27W | Patent revoked |
Effective date: 19930304 |
|
GBPR | Gb: patent revoked under art. 102 of the ep convention designating the uk as contracting state |
Free format text: 930304 |
|
NLR2 | Nl: decision of opposition |